SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global immune health supplements market is estimated to be valued at US$ 14,913.8 million in 2020 and is expected to exhibit a CAGR of 6.1% during the forecast period (2020-2027).
Key Trends and Analysis:
The global immune health supplements market is expected to witness significant growth, owing to rising incidence of chronic diseases. For instance, according to the European Cardiovascular Disease Statistics 2017, each year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU).
Launches of products are also expected to drive growth of the global immune health supplements market. For instance, in April 2020, International Cannabrands Inc., dba Radiko Holdings Company launched its in-house brand 'baseline', a new immunity-focused product.
For instance, in April 2020, Vitality Wellness, a New Zealand-based company, launched immune health supplements made from blackcurrants to address nutritional demands amid the COVID 19 outbreak in New Zealand. The product contains 35% blackcurrant extract, 300mg of Vitamin C, 18mg Vitamin D3, and 10mg Zinc. The product was also launched in Singapore in May 2020.
For instance, in 2019, BioGaia launched BioGaia Osfortis, a vitamin D supplement for bone health and also, the product is marketed by Everidis Health Sciences in the U.S.
Request for Sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/4065
Furthermore, major players are focusing on adopting strategies such as mergers and acquisitions to gain dominant position and hold major share in the immune health supplements market. For instance, in December 2018, Pfizer Inc. and GlaxoSmithKline plc (GSK) announced plans for its joint venture agreement to create a global consumer healthcare company. This joint venture will expand GSK’s consumer health portfolio towards vitamin and dietary supplements category. For instance, in October 2019, Ashland signed a licensing agreement with Clasado BioSciences to expand health and wellness portfolio with Bimuno prebiotics.
Key Market Takeaways:
North America is expected to be the most lucrative region in the immune health supplements market due to the launch of new products. For instance, in March 2019, EuroPharma, Inc., makers of the Terry Naturally brand of dietary supplements, launched CuraMed 500 mg for better absorption, blood retention, and immune health.
Key players operating in the global immune health supplements market include EuroPharma, Inc., Glanbia, Plc., Bio Tech Pharmacal, Cellderm Technologies Inc., Bayer AG, Vital Nutrients, NutriGold Inc., Daflorn Ltd., BioGaia, and Seroyal
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4065
Global Immune Health Supplements Market, By Ingredients:
- Omega 3 fatty Acids
- Others (amino acids, herbal and botanical extract)
Global Immune Health Supplements Market, By Source:
Global Immune Health Supplements Market, By Form:
Global Immune Health Supplements Market, By Distribution Channel:
- Retail Pharmacies
- Online Pharmacies
Global Immune Health Supplements Market, By Region:
- Rest of Europe
- South Korea
- Rest of Asia Pacific
- Rest of Latin America
- Rest of Middle East
- South Africa
- Central Africa
- North Africa
- North America
Related Market Intelligence Report:
Somatropin Market, By Dosage Form (Powder and Solvent), By Application (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age, SHOX Deficiency, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.